ArticleCirculation. Genomic and precision medicine2025

Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study.

Eloi Gagnon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.